Bill116th CongressFiled Mar 18, 2019Health
H.Res. 242
Affirming the importance of the Orphan Drug Act, celebrating the over 750 new orphan therapies approved since its creation, and recognizing the need to continue supporting research and development for rare diseases.
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Mar 18, 2019)
This resolution applauds the growth in research and development into new therapies for rare diseases and recognizes that significant research and development efforts and related investments are needed to develop therapies to treat and cure thousands of rare diseases for which no treatment options are currently available.
What just happenedMar 19, 2019
Referred to the Subcommittee on Health.
Who’s behind it
Rep. Butterfield, G. K. [D-NC-1](D-NC)Sponsor
6 cosponsors4 D2 R
6cosponsors1committees4actions10subjects
- Introduced in HouseMar 18, 2019
- Mar 19, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Mar 18, 2019IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Mar 18, 2019IntroReferralIntro-H
Introduced in House
- Mar 18, 2019IntroReferral1000
Introduced in House